ArticlePharmaceuticals (Basel, Switzerland)2024

Safety Evaluation of the Combination with Dexrazoxane and Anthracyclines: A Disproportionality Analysis Based on the Food and Drug Administration Adverse Event Reporting System Database.

Danyi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.